Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Saving orphans: BRAF targeting of histiocytosis.
[erdheim-chester disease]
In
this
issue
of
Blood
,
Haroche
and
colleagues
report
significant
therapeutic
activity
of
the
BRAF
inhibitor
,
vemurafenib
,
in
3
patients
with
rare
histiocytic
conditions
,
Erdheim-
Chester
disease
and
Langerhans
cell
histiocytosis
.